Yarnold JR - Search Results

1

Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial.

Coles CE, Haviland JS, Kirby AM, Griffin CL, Sydenham MA, Titley JC, Bhattacharya I, Brunt AM, Chan HYC, Donovan EM, Eaton DJ, Emson M, Hopwood P, Jefford ML, Lightowlers SV, Sawyer EJ, Syndikus I, Tsang YM, Twyman NI, Yarnold JR, Bliss JM; IMPORT Trial Management Group. Coles CE, et al. Among authors: yarnold jr. Lancet. 2023 Jun 24;401(10394):2124-2137. doi: 10.1016/S0140-6736(23)00619-0. Epub 2023 Jun 8. Lancet. 2023. PMID: 37302395 Free article. Clinical Trial.

2

Treatment of early breast cancer.

Bliss JM, Yarnold JR. Bliss JM, et al. Among authors: yarnold jr. Lancet. 1992 Apr 11;339(8798):936. doi: 10.1016/0140-6736(92)90981-8. Lancet. 1992. PMID: 1348335 No abstract available.

3

Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity.

Burnet NG, Nyman J, Turesson I, Wurm R, Yarnold JR, Peacock JH. Burnet NG, et al. Among authors: yarnold jr. Lancet. 1992 Jun 27;339(8809):1570-1. doi: 10.1016/0140-6736(92)91833-t. Lancet. 1992. PMID: 1351551

4

The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity.

Moody AM, Mayles WP, Bliss JM, A'Hern RP, Owen JR, Regan J, Broad B, Yarnold JR. Moody AM, et al. Among authors: yarnold jr. Radiother Oncol. 1994 Nov;33(2):106-12. doi: 10.1016/0167-8140(94)90063-9. Radiother Oncol. 1994. PMID: 7708953 Clinical Trial.

5

Benefits of post-mastectomy radiotherapy.

Yarnold J. Yarnold J. Lancet. 1997 Nov 15;350(9089):1415-6. doi: 10.1016/S0140-6736(05)64204-3. Lancet. 1997. PMID: 9371162 No abstract available.

6

The effectiveness of the routine clinic visit in the follow-up of breast cancer patients: analysis of a defined patient cohort.

Loong S, Wilkins M, Bliss JM, Davidson J, Ebbs SR, Regan J, Yarnold JR. Loong S, et al. Among authors: yarnold jr. Clin Oncol (R Coll Radiol). 1998;10(2):103-6. doi: 10.1016/s0936-6555(05)80488-1. Clin Oncol (R Coll Radiol). 1998. PMID: 9610899

7

Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients.

Shayeghi M, Seal S, Regan J, Collins N, Barfoot R, Rahman N, Ashton A, Moohan M, Wooster R, Owen R, Bliss JM, Stratton MR, Yarnold J. Shayeghi M, et al. Br J Cancer. 1998 Oct;78(7):922-7. doi: 10.1038/bjc.1998.602. Br J Cancer. 1998. PMID: 9764584 Free PMC article. Clinical Trial.

8

Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial.

Dearnaley DP, Khoo VS, Norman AR, Meyer L, Nahum A, Tait D, Yarnold J, Horwich A. Dearnaley DP, et al. Lancet. 1999 Jan 23;353(9149):267-72. doi: 10.1016/S0140-6736(98)05180-0. Lancet. 1999. PMID: 9929018 Clinical Trial.

9

Practical implementation of compensators in breast radiotherapy.

Evans PM, Donovan EM, Fenton N, Hansen VN, Moore I, Partridge M, Reise S, Suter B, Symonds-Tayler JR, Yarnold JR. Evans PM, et al. Among authors: yarnold jr. Radiother Oncol. 1998 Dec;49(3):255-65. doi: 10.1016/s0167-8140(98)00126-1. Radiother Oncol. 1998. PMID: 10075258

10

Evaluation of compensation in breast radiotherapy: a planning study using multiple static fields.

Donovan EM, Johnson U, Shentall G, Evans PM, Neal AJ, Yarnold JR. Donovan EM, et al. Among authors: yarnold jr. Int J Radiat Oncol Biol Phys. 2000 Feb 1;46(3):671-9. doi: 10.1016/s0360-3016(99)00388-0. Int J Radiat Oncol Biol Phys. 2000. PMID: 10701747

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

226 results

Search Page